AI Article Synopsis
- The study aimed to analyze the variations and importance of serum ferritin levels in Chinese patients with blood cancers, specifically hematologic malignancies.* -
- A total of 473 patients were included, with notable diagnoses being acute leukemia, lymphoma, and multiple myeloma, and results showed higher serum ferritin levels in newly diagnosed and recurrent cases compared to those in remission.* -
- The findings suggest that monitoring serum ferritin levels can be useful for evaluating the health status and prognosis of patients with hematologic malignancies.*
Article Abstract
Purpose: To retrospectively analyze variability and clinical significance of serum ferritin levels in Chinese patients with hematologic malignancies.
Materials And Methods: Serum ferritin were measured by radioimmunoassay, using a kit produced by the Beijing Institute of Atomic Energy. Patients with hematologic malignancies, and treated in the Department of Hematology in Nanjing First Hospital and fulfilled study criteria were recruited.
Results: Of 473 patients with hematologic malignancies, 262 patients were diagnosed with acute leukemia, 131 with lymphoma and 80 with multiple myeloma. Serum ferritin levels of newly diagnosed and recurrent patients were significantly higher than those entering complete remission stage or in the control group (p<0.001).
Conclusions: Serum ferritin lever in patients with hematologic malignancies at early stage and recurrent stage are significantly increased, so that detection and surveillance of changes of serum ferritin could be helpful in assessing conditions and prognosis of this patient cohort.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7314/apjcp.2014.15.15.6099 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!